11 Jun, 2009
Study Suggests Drug Rapamune Increases Risk of Death
Posted by: Natural Medicine In: Medical
FDA notified healthcare professionals of clinical trial data that suggest increased mortality in stable liver transplant patients after conversion from a calcineurin inhibitor (CNI)-based immunosuppressive regimen to sirolimus (Rapamune). The trial was conducted by sirolimus manufacturer, Wyeth. The Agency will continue to examine the data on mortality and other adverse events in this study, and [...]
Go Back
